JIANJUN GAO to B7-H1 Antigen
This is a "connection" page, showing publications JIANJUN GAO has written about B7-H1 Antigen.
Connection Strength
0.763
-
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. Nat Med. 2017 May; 23(5):551-555.
Score: 0.345
-
Emerging treatments in advanced urothelial cancer. Curr Opin Oncol. 2020 05; 32(3):232-239.
Score: 0.107
-
The emerging role of immunotherapy in advanced urothelial cancers. Curr Opin Oncol. 2018 05; 30(3):172-180.
Score: 0.093
-
Five new therapies or just one new treatment? A critical look at immune checkpoint inhibition in urothelial cancer. Immunotherapy. 2017 09; 9(10):781-784.
Score: 0.089
-
The State of Immune Checkpoint Inhibition in Urothelial Carcinoma: Current Evidence and Future Areas of Exploration. Cancer J. 2016 Mar-Apr; 22(2):96-100.
Score: 0.080
-
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. Nat Commun. 2021 09 23; 12(1):5606.
Score: 0.029
-
Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma. Cancer Immunol Res. 2015 Sep; 3(9):1017-29.
Score: 0.019